PubMed Health⌕ Search

Biomedical subjects

C Webster

Publications and source records attributed to C Webster.

At least 109 records · Page 6Linked to original sources

Failure of bacterial filters to reduce the incidence of pneumonia after inhalation anesthesia.

The authors prospectively studied 520 patients undergoing inhalation anesthesia to evaluate the efficacy of low resistance 0.22-micron bacterial filters in preventing postoperative pneumonias. Patients undergoing elective thoracic, upper abdominal and lower abdominal surgeries were randomly assigned preoperatively to filtered and nonfiltered anesthesia circuits by a study nurse. A second study nurse, who was unaware of patient assignments, followed each patient for five postoperative days to identify possible pulmonary complications. Both groups of patients were similar in age, sex distribution, smoking history, prior pulmonary disease, types and duration of surgery, ASA physical status classification, and receipt of intraoperative antibiotics. No differences in rates of postoperative pneumonia were observed between patients assigned to filtered and nonfiltered circuits (16.7 per cent vs. 18.3 per cent, respectively, P = 0.73). Also no differences were observed when the incidences of other outcome criteria such as postoperative fever, abnormal chest x-ray, sputum production, or abnormal pulmonary physical exam findings were evaluated. The results suggest that bacterial gas filters do not influence the incidence of postoperative pneumonias and that routine use of these devices for this purpose is not cost-effective.

Anesthesia, Inhalation↗

Naratriptan is effective and well tolerated in the acute treatment of migraine. Results of a double-blind, placebo-controlled, parallel-group study. Naratriptan S2WA3001 Study Group.

OBJECTIVE: To evaluate the efficacy and tolerability of naratriptan, a novel 5-HT1 agonist, in the acute treatment of migraine. DESIGN/METHODS: Six hundred thirteen migraineurs, diagnosed according to International Headache Society criteria, treated a single migraine attack with naratriptan tablets (2.5 mg, 1 mg, 0.25 mg, or 0.1 mg) or placebo in a randomized, double-blind, placebo-controlled, parallel-group study conducted at 54 United States centers. At dosing and at predetermined intervals beginning 30 minutes postdose, patients recorded migraine pain severity, clinical disability, and presence of associated migraine symptoms. Safety measures included adverse events, physical examinations, vital signs, ECGs, and clinical laboratory tests. RESULTS: Headache relief (moderate or severe pain at dosing reduced to mild or no pain) 4 hours postdose was reported in 60% of patients receiving naratriptan 2.5 mg compared with 50%, 35%, 32%, and 34% of patients receiving naratriptan 1 mg, 0.25 mg, 0.1 mg, and placebo, respectively (P < 0.05 naratriptan 2.5 mg and 1 mg versus placebo, 1 mg versus 0.1 mg, and 2.5 mg versus 0.1 mg and 0.25 mg). Clinical disability 4 hours postdose was reported as mild or none for 70% of patients receiving naratriptan 2.5 mg compared with 63%, 47%, 48%, and 48% of patients receiving naratriptan 1 mg, 0.25 mg, 0.1 mg, or placebo, respectively (P < 0.05 naratriptan 2.5 mg and 1 mg versus placebo, 1 mg versus 0.1 mg, and 2.5 mg versus 0.1 mg and 0.25 mg). Four-hour efficacy for absence of nausea, photophobia, and phonophobia was similar to efficacy for headache relief at each dose. The adverse event profile of each dose of naratriptan was similar to that of placebo. No clinically relevant change in any safety measure was reported. CONCLUSIONS: Naratriptan is effective and well tolerated for the acute treatment of migraine. The 2.5-mg dose appears to offer the optimum ratio of efficacy to tolerability.

Acute Disease↗

Structured data entry in a workflow-enabled electronic patient record.

Touch-screen technology is used with a structured data entry system for electronic patient records. This article describes a program that coordinates pre-set screens for detailed history, physical examination, treatment and prescription modules. It also presents "pick lists" that allow further customization and individualization of data inputs.

Data Display↗